Please ensure Javascript is enabled for purposes of website accessibility

Moderna Has Shipped 100 Million Coronavirus Vaccine Doses to the U.S.

By Eric Volkman - Mar 29, 2021 at 4:14PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

More than two-thirds of those jabs have already been administered.

On Monday, Moderna (MRNA 4.97%) reached a significant milestone in the battle against the pandemic: The company announced that it had shipped the 100 millionth dose of its mRNA-1273 coronavirus vaccine to the U.S. government.

The majority of those have already found their way into American arms. Moderna cited Centers for Disease Control and Prevention figures showing that around 67 million doses of mRNA-1273 have been administered in the country so far.

A syringe being filled with a vaccine from a vial.

Image source: Getty Images.

Moderna's jab is one of three vaccines for the coronavirus that have thus far received emergency use authorizations (EUA) from the Food and Drug Administration. The two others were developed by Pfizer and BioNTech BNT-162b2, and Johnson & Johnson unit Janssen.

"I would like to thank the millions of people who have put their confidence in Moderna's science and our COVID-19 vaccine," said CEO Stephane Bancel. 

"We are humbled to know that we are helping address this worldwide pandemic with our vaccine," he added.

The FDA granted mRNA-1273 its EUA on Dec. 18. Since then, according to Moderna, it has ramped up shipments. These stood at over 16 million doses in Q4, a number that has risen dramatically to 88 million to date in Q1. In order to fulfill its standing commitment to the government, the company plans to provide an additional 40 to 50 million doses per month. All ordered doses should be delivered by the end of July.

Monday, however, wasn't a good day for the company on Wall Street. Its shares fell by 7.4%, while the S&P 500 index closed the trading session essentially flat.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Moderna, Inc. Stock Quote
Moderna, Inc.
MRNA
$149.95 (4.97%) $7.10
Pfizer Inc. Stock Quote
Pfizer Inc.
PFE
$52.31 (-0.23%) $0.12
Johnson & Johnson Stock Quote
Johnson & Johnson
JNJ
$179.52 (1.13%) $2.01
BioNTech SE Stock Quote
BioNTech SE
BNTX
$157.50 (5.63%) $8.40

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
316%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/03/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.